Eyob D. Adane

Pharmacokinetics of Vancomycin in Extremely Obese Patients with Suspected or Confirmed <i><scp>S</scp>taphylococcus aureus</i> Infections

Eyob D. Adane, Michael Herald, Firas Koura · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2015 · 103 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations

Pieter Colin, Karel Allegaert, Alison H. Thomson et al. · Clinical Pharmacokinetics · 2019 · 92 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Factors Affecting the In Vivo Lactone Stability and Systemic Clearance of the Lipophilic Camptothecin Analogue AR-67

Eyob D. Adane, Zhiwei Liu, Tian‐Xiang Xiang et al. · Pharmaceutical Research · 2010 · 13 citations

Pharmacy, Pharmacokinetics, Pharmacology +5

The Effect of Breast Cancer Resistance Protein, Multidrug Resistant Protein 1, and Organic Anion-Transporting Polypeptide 1B3 on the Antitumor Efficacy of the Lipophilic Camptothecin 7-t-Butyldimethylsilyl-10-Hydroxycamptothecin (AR-67) In Vitro

Eleftheria Tsakalozou, Eyob D. Adane, Kuei‐Ling Kuo et al. · Drug Metabolism and Disposition · 2013 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacokinetic Modeling to Assess Factors Affecting the Oral Bioavailability of the Lactone and Carboxylate Forms of the Lipophilic Camptothecin Analogue AR-67 in Rats

Eyob D. Adane, Zhiwei Liu, Tian‐Xiang Xiang et al. · Pharmaceutical Research · 2011 · 10 citations

Pharmacy, Pharmacokinetics, Pharmacology +16